Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany K Pon

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Seminars in Dialysis|May 9, 2015
Considerations for Systemic Anticoagulation in ESRDWilliam E Dager, Laura V Tsu, Tiffany K Pon
Hospital Pharmacy|July 28, 2022
Pharmacy Resident Perspectives on the Layered Learning Practice ModelNathan V Dang, Tiffany K Pon, Yvette M Hellier
Thrombosis Research|April 11, 2014
Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patientsTiffany K Pon, William E Dager, A Joshua Roberts, et al.
International Journal of Clinical Pharmacy|January 21, 2019
Utilization of venous thromboembolism prophylaxis in American hospitalized pregnant women undergoing cesarean sectionTiffany K Pon, Natalie Wessel, Vincent Cagonot, et al.
Thrombosis Research|November 19, 2021
Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumorsAngela Lee, Frank Oley, Mimi Lo, et al.
Journal of Thrombosis and Thrombolysis|March 26, 2018
Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopeniaTiffany K Pon, Anjlee Mahajan, Aaron Rosenberg, et al.
The Annals of Pharmacotherapy|November 14, 2025
Assessment of Guideline-Directed Medical Therapy Optimization Scores and Readmission Risk in Heart Failure With Reduced Ejection FractionHanna Jensen, Max Staskauskas, Sara Strome, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Seminars in Dialysis|May 9, 2015
Considerations for Systemic Anticoagulation in ESRDWilliam E Dager, Laura V Tsu, Tiffany K Pon
Hospital Pharmacy|July 28, 2022
Pharmacy Resident Perspectives on the Layered Learning Practice ModelNathan V Dang, Tiffany K Pon, Yvette M Hellier
Thrombosis Research|April 11, 2014
Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patientsTiffany K Pon, William E Dager, A Joshua Roberts, et al.
International Journal of Clinical Pharmacy|January 21, 2019
Utilization of venous thromboembolism prophylaxis in American hospitalized pregnant women undergoing cesarean sectionTiffany K Pon, Natalie Wessel, Vincent Cagonot, et al.
Thrombosis Research|November 19, 2021
Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumorsAngela Lee, Frank Oley, Mimi Lo, et al.
Journal of Thrombosis and Thrombolysis|March 26, 2018
Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopeniaTiffany K Pon, Anjlee Mahajan, Aaron Rosenberg, et al.
The Annals of Pharmacotherapy|November 14, 2025
Assessment of Guideline-Directed Medical Therapy Optimization Scores and Readmission Risk in Heart Failure With Reduced Ejection FractionHanna Jensen, Max Staskauskas, Sara Strome, et al.
Pageof 1